Novogene Europe has expanded its multiomics portfolio with the launch of a new Untargeted Metabolomics Service at its Cambridge Omics Centre, providing researchers across the UK and Europe with deeper insight into biological function by integrating metabolite analysis alongside genomic and transcriptomic data.
The new service enables scientists to investigate the small molecules that directly influence cellular activity, helping bridge the gap between molecular data and observable biological outcomes. By combining metabolomics with genomics, transcriptomics and microbiome analysis, researchers can gain a more comprehensive understanding of disease mechanisms, biomarker discovery, treatment response and complex biological pathways.
The workflow is powered by Thermo Scientific Vanquish UHPLC technology coupled with Orbitrap Exploris 120 high-resolution mass spectrometry, delivering detailed metabolite profiling across a wide range of biological samples. Supported by an extensive reference library and Novogene Europe's established bioinformatics expertise, the service is designed to help academic, biotechnology and pharmaceutical researchers generate meaningful biological insights from increasingly complex datasets.
The introduction of metabolomics marks the first phase of an ongoing expansion at the Cambridge Omics Centre, located within the Bio-Innovation Centre in Cambridge. The investment further strengthens Novogene Europe's position as a comprehensive multiomics research partner, offering integrated services that support projects from experimental design through data generation and biological interpretation.
By adding metabolomics to its growing portfolio, Novogene Europe is providing researchers with another powerful tool to connect molecular information with functional biology, enabling a more complete picture of complex biological systems.
Watch the introductory video to discover how untargeted metabolomics can enhance your next multiomics study and reveal new biological insights.
